User:Paektu41/sandbox

Nacimbio (also wrote as Natsimbio), or OJSC National Immunobiological Company, is a subsidiary of the Rostec state corporation in Russia and was established in 2013 as apart of an effort by the Government of Russia to achieve independence in the production of pharmaceutical products, particularly those for the treatment of communicable diseases.

Ownership
Nacimbio is a state owned enterprise in Russia, with Rostec holding a 75% stake in the company, with the remaining 25% stake owned by Russian investment firm Marathon group.

Products
The company focuses on developing productsin 5 key areas of the Pharmaceuticals sector: Vaccines, Tuberculosis, HIV and hepatitis, haematology and insulin. In addition to this, the company has recently begun devlopment on a combined Flu and Coronavirus vaccine.

Subsidiaries
-NGO "Microgen"

-"FORT"

-"Synthesis"

-MPO Metalist

The company also holds a 37% stake in Kirov Plasma.